Shree Ganesh Remedies Ltd Financials
Company Logo

Shree Ganesh Remedies Ltd Financial Statement

Shree Ganesh Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue25.32
Operating Expense16.66
Net Profit4.65
Net Profit Margin18.36
Earning Per Share3.62
EBIDTA8.65
Effective Tax Rate19.15

Shree Ganesh Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual90.22
Operating Expenses Annual66.96
Operating Profit Annual26.42
Interest Annual0.12
Depreciation3.72
Net Profit Annual17.02
Tax Annual5.56

Shree Ganesh Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning3.88
Cash Flow from Operations17.01
Cash Flow from Investing-53.57
Cash Flow from Financing41.33
Cash Flow at the End8.65

Shree Ganesh Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)29.30
PBIT Margin (%)25.17
PBT Margin (%)-184.51
Net PROFIT Margin (%)18.86
Return On Networth / Equity (%)22.61
Return On Networth /Employed (%)24.61
Return On Assets (%)18.49
Total Debt / Equity (X)0.22
Asset Turnover Ratio (%)0.98

Shree Ganesh Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual36.25
Total Current Assets Annual64.29
Non Current Assets Annual79.54
Total Shareholders Funds Annual88.94
Total Assets Annual143.83

Shree Ganesh Remedies Ltd Earning Calls

EPS (INR)

Expected

3.62

Reported

3.62

Surprise

0.00%

Mar 2024

EPS beaten by 0.00%

Dec 2021

EPS beaten by 0.00%

Sep 2021

EPS beaten by 0.00%

Get Your FAQs Right

As of Sep 12, 2024, Shree Ganesh Remedies Ltd has a market capitalization of 801.21 Cr. Value Research classifies it as a Small-Cap company.
Yes, Shree Ganesh Remedies Ltd is debt-free with a debt-to-equity ratio of 0.30.
In FY 2023 , Shree Ganesh Remedies Ltd recorded a total revenue of approximately 125.90 Cr marking a significant milestone in the company's financial performance.
Shree Ganesh Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.4% and 0.3% annually, respectively..
Shree Ganesh Remedies Ltd's current PE ratio is 28.49.
Shree Ganesh Remedies Ltd's ROCE averaged 23.6% from the FY ending March 2022 to 2024, with a median of 24.5%. It peaked at 29.5% in March 2022, reflecting strong capital efficiency over the period..
Shree Ganesh Remedies Ltd's latest EBIT is Rs. 38.77 Cr, surpassing the average EBIT of Rs. 25.78 Cr over the 5 years..